Literature DB >> 29778633

Comparative analysis of proteinase, phospholipase, hydrophobicity and biofilm forming ability in Candida species isolated from clinical specimens.

S Dabiri1, M Shams-Ghahfarokhi2, M Razzaghi-Abyaneh3.   

Abstract

Candida species are the commensal organisms of human and animal mucosa that cause a wide range of debilitating diseases in immunocompromised patients and other susceptible individuals. The present study aimed to investigate the ability of clinical isolates of various Candida species to produce proteinase and phospholipase, hydrophobicity and biofilm forming ability that assumed to have a vital role in Candida pathogenicity. Eighty-four Candida strains belonged to Candida albicans (44.1%), C. glabrata (5.9%), C. guilliermondii (5.9%), C. krusei (10.8%), C. parapsilosis (26.2%), and C. tropicalis (7.1%) were examined for proteinase and phospholipase production, cell surface hydrophobicity and biofilm forming ability. The production of proteinase and phospholipase was detected in 81 (96.4%) and 79 (94.1%) of the strains, respectively. C. albicans showed the highest proteinase and phospholipase activity (mean Pz values of 0.42±0.25 and 0.72±0.28) and biofilm formation ability (0.66±0.22). C. parapsilosis had the highest hydrophobicity (42.97±16.1), which showed a good correlation with biofilm formation ability. A considerable percentage of non-albicans Candida strains produced significant amounts of proteinase and phospholipase with a good ability of biofilm formation in vitro. Taken together, our results further substantiated that enzymatic activity, hydrophobicity and the ability for biofilm formation are important virulence factors which may be account for pathogenicity of various Candida species distributed in albicans and non-albicans groups.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biofilm formation; Candida species; Hydrophobicity; Phospholipase; Proteinase; Virulence factors

Mesh:

Substances:

Year:  2018        PMID: 29778633     DOI: 10.1016/j.mycmed.2018.04.009

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  7 in total

1.  Secretory Proteases of the Human Skin Microbiome.

Authors:  Wisely Chua; Si En Poh; Hao Li
Journal:  Infect Immun       Date:  2021-10-04       Impact factor: 3.609

2.  Evaluation of biofilm formation in the homozygous and heterozygous strains of vaginal Candida albicans isolates.

Authors:  Keyvan Pakshir; Sahar Sheykhi; Kamiar Zomorodian; Hasti Nouraei; Zahra Zare Shahrabadi
Journal:  Curr Med Mycol       Date:  2019-06

Review 3.  Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis.

Authors:  Carmen Rodríguez-Cerdeira; Erick Martínez-Herrera; Miguel Carnero-Gregorio; Adriana López-Barcenas; Gabriella Fabbrocini; Monika Fida; May El-Samahy; José Luís González-Cespón
Journal:  Front Microbiol       Date:  2020-11-11       Impact factor: 5.640

Review 4.  Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi.

Authors:  Carina Danchik; Arturo Casadevall
Journal:  Front Cell Infect Microbiol       Date:  2021-01-25       Impact factor: 5.293

5.  Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis.

Authors:  Hadis Jafarian; Maral Gharaghani; Seyed Saeed Seyedian; Ali Zarei Mahmoudabadi
Journal:  J Clin Lab Anal       Date:  2021-05-14       Impact factor: 2.352

6.  Cutaneous candidiasis in Tehran-Iran: from epidemiology to multilocus sequence types, virulence factors and antifungal susceptibility of etiologic Candida species.

Authors:  Golnar Sadeghi; Mina Ebrahimi-Rad; Masoomeh Shams-Ghahfarokhi; Zahra Jahanshiri; Esmat Mirabzadeh Ardakani; Ali Eslamifar; Seyed Fazlollah Mousavi; Mehdi Razzaghi-Abyaneh
Journal:  Iran J Microbiol       Date:  2019-08

7.  Effect of Carum carvi essential oil on ERG6 gene expression and virulence factors in Candida albicans.

Authors:  Samira Nasiri; Masoomeh Shams Ghahfarokhi; Mehdi Razzaghi Abyaneh
Journal:  Curr Med Mycol       Date:  2020-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.